Skip to main content

Advertisement

Log in

Prognostic Significance of Tumor Necrosis in Hilar Cholangiocarcinoma

  • Hepatobiliary Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Tumor necrosis and peritumoral fibrosis have both been suggested to have a prognostic value in selected solid tumors. However, little is known regarding their influence on tumor progression and prognosis in hilar cholangiocarcinoma (HC).

Methods

Surgically resected tumor specimens of HC (n = 47) were analyzed for formation of necrosis and extent of peritumoral fibrosis. Tumor necrosis and grade of fibrosis were assessed histologically and correlated with clinicopathological characteristics, tumor recurrence, and patients’ survival. Univariate Kaplan–Meier analysis and a stepwise multivariable Cox regression model were applied.

Results

Mild peritumoral fibrosis was evident in 12 tumor samples, moderate peritumoral fibrosis in 20, and high-grade fibrosis in 15. Necrosis was evident in 19 of 47 tumor samples. Patients with tumors characterized by necrosis showed a significantly decreased 5-year recurrence-free survival (37.9 vs. 25.7 %; p < .05) and a significantly decreased 5-year overall survival (42.6 vs. 12.4 %; p < .05), when compared with patients with tumors showing no necrosis. R status, tumor recurrence, and tumor necrosis were of prognostic value in the univariate analysis (all p < .05). Multivariate survival analysis confirmed tumor necrosis (p = .038) as the only independent prognostic variable.

Conclusions

The assessment of tumor necrosis appears as a valuable additional prognostic tool in routine histopathological evaluation of HC. These observations might have implications for monitoring and more individualized multimodal therapeutic strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Neuhaus P, Jonas S, Bechstein WO, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg. 1999;230:808–18 (discussion 819).

  2. Jonas S, Steinmüller T, Neuhaus P. [Surgical therapy of liver hilus tumors]. Chirurg. 2001;72:775–83.

    Article  CAS  PubMed  Google Scholar 

  3. Neuhaus P, Thelen A, Jonas S, Puhl G, Denecke T, Veltzke-Schlieker W, Seehofer. Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma. Ann Surg Oncol. 2012;19:1602–8.

    Article  PubMed  Google Scholar 

  4. Wiltberger G, Krenzien F, Benzing C, et al. Prognostic accuracy of the seventh edition of the TNM classification compared with the fifth and sixth edition for distal cholangiocarcinoma. Ann Surg Oncol. 2016;23:1320–6.

    Article  PubMed  Google Scholar 

  5. Juntermanns B, Sotiropoulos GC, Radunz S, et al. Comparison of the sixth and the seventh editions of the UICC classification for perihilar cholangiocarcinoma. Ann Surg Oncol. 2013;20:277–84.

    Article  PubMed  Google Scholar 

  6. Zaydfudim VM, Clark CJ, Kendrick ML, et al. Correlation of staging systems to survival in patients with resected hilar cholangiocarcinoma. Am J Surg. 2013;206:159–65.

    Article  PubMed  Google Scholar 

  7. Ebata T, Kosuge T, Hirano S, et al. Proposal to modify the International Union Against Cancer staging system for perihilar cholangiocarcinomas. Br J Surg. 2014;101:79–88.

    Article  CAS  PubMed  Google Scholar 

  8. Válek V, Kysela P, Kala Z, Kiss I, Tomásek J, Petera J. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study. Eur J Radiol. 2007;62:175–9.

    Article  PubMed  Google Scholar 

  9. Hickey R, Mulcahy MF, Lewandowski RJ, et al. Chemoradiation of hepatic malignancies: prospective, phase 1 study of full-dose capecitabine with escalating doses of yttrium-90 radioembolization. Int J Radiat Oncol Biol Phys. 2014;88:1025–31.

    Article  PubMed  Google Scholar 

  10. Chen Y, Wang XL, Yan ZP, et al. HDR-192Ir intraluminal brachytherapy in treatment of malignant obstructive jaundice. World J Gastroenterol. 2004;10:3506–10.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Richards CH, Mohammed Z, Qayyum T, Horgan PG, McMillan DC. The prognostic value of histological tumor necrosis in solid organ malignant disease: a systematic review. Future Oncol. 2011;7:1223–35.

    Article  CAS  PubMed  Google Scholar 

  12. Cornfield DB, Palazzo JP, Schwartz GF, et al. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone. Cancer. 2004;100:2317–27.

    Article  PubMed  Google Scholar 

  13. Pearlman BL, Traub N. Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more. Clin Infect Dis. 2011;52:889–900.

    Article  PubMed  Google Scholar 

  14. Valent P, Orazi A, Büsche G, et al. Standards and impact of hematopathology in myelodysplastic syndromes (MDS). Oncotarget. 2010;1:483–96.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Nakeeb A, Pitt HA. Radiation therapy, chemotherapy and chemoradiation in hilar cholangiocarcinoma. HPB (Oxford). 2005;7:278–82.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Rizvi S, Borad MJ, Patel T, Gores GJ. Cholangiocarcinoma: molecular pathways and therapeutic opportunities. Semin Liver Dis. 2014;34:456–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Atanasov G, Hau HM, Dietel C, et al. Prognostic significance of macrophage invasion in hilar cholangiocarcinoma. BMC Cancer. 2015;15:790.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Pollheimer MJ, Kornprat P, Lindtner RA, Harbaum L, Schlemmer A, Rehak P, Langner C. Tumor necrosis is a new promising prognostic factor in colorectal cancer. Hum Pathol. 2010;41:1749–57.

    Article  CAS  PubMed  Google Scholar 

  19. Pichler M, Hutterer GC, Chromecki TF, et al. Histologic tumor necrosis is an independent prognostic indicator for clear cell and papillary renal cell carcinoma. Am J Clin Pathol. 2012;137:283–9.

    Article  PubMed  Google Scholar 

  20. Gerlach UA, Atanasov G, Wallenta L, et al. Short-term TNF-alpha inhibition reduces short-term and long-term inflammatory changes post-ischemia/reperfusion in rat intestinal transplantation. Transplantation. 2014;97:732–9.

    Article  CAS  PubMed  Google Scholar 

  21. Gacci M, Serni S, Lapini A, et al. CXCR3-B expression correlates with tumor necrosis extension in renal cell carcinoma. J Urol. 2009;181:843–8.

    Article  CAS  PubMed  Google Scholar 

  22. Saxena A, Chua TC, Chu FC, Morris DL. Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival. Am J Surg. 2011;202:310–20.

    Article  PubMed  Google Scholar 

  23. Young AL, Igami T, Senda Y, et al. Evolution of the surgical management of perihilar cholangiocarcinoma in a Western centre demonstrates improved survival with endoscopic biliary drainage and reduced use of blood transfusion. HPB (Oxford). 2011;13:483–93.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Zheng-Rong L, Hai-Bo Y, Xin C, et al. Resection and drainage of hilar cholangiocarcinoma: an 11-year experience of a single center in mainland China. Am Surg. 2011;77:627–33.

    PubMed  Google Scholar 

  25. Tian X, Wang Q, Li Y, Hu J, Wu L, Ding Q, Zhang C. The expression of S100A4 protein in human intrahepatic cholangiocarcinoma: clinicopathologic significance and prognostic value. Pathol Oncol Res. 2015;21:195–201.

    Article  CAS  PubMed  Google Scholar 

  26. Huang C, Tian Y, Peng R, et al. Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection. J Gastroenterol Hepatol. 2015;30:421–33.

    Article  CAS  PubMed  Google Scholar 

  27. Thongchot S, Yongvanit P, Loilome W, et al. High expression of HIF-1α, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis. Asian Pac J Cancer Prev. 2014;15:5873–8.

    Article  PubMed  Google Scholar 

  28. Gao Q, Yu GY, Shi JY, et al. Neddylation pathway is up-regulated in human intrahepatic cholangiocarcinoma and serves as a potential therapeutic target. Oncotarget. 2014;5:7820–32.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Seubwai W, Wongkham C, Puapairoj A, et al. Aberrant expression of NF-κB in liver fluke associated cholangiocarcinoma: implications for targeted therapy. PLoS One. 2014;9:e106056.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Saha SK, Parachoniak CA, Ghanta KS, et al. Corrigendum: Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer. Nature. 2015;528:152.

    CAS  PubMed  Google Scholar 

  31. Al Faraj A, Shaik AS, Pureza MA, Alnafea M, Halwani R. Preferential macrophage recruitment and polarization in LPS-induced animal model for COPD: noninvasive tracking using MRI. PLoS One. 2014;9:e90829.

    Article  Google Scholar 

  32. Al Faraj A, Luciani N, Kolosnjaj-Tabi J, Mattar E, Clement O, Wilhelm C, Gazeau F. Real-time high-resolution magnetic resonance tracking of macrophage subpopulations in a murine inflammation model: a pilot study with a commercially available cryogenic probe. Contrast Media Mol Imaging. 2013;8:193–203.

    Article  CAS  Google Scholar 

  33. Locke LW, Mayo MW, Yoo AD, Williams MB, Berr SS. PET imaging of tumor associated macrophages using mannose coated 64Cu liposomes. Biomaterials. 2012;33:7785–93.

    Article  CAS  PubMed  Google Scholar 

  34. Jacoby C, Borg N, Heusch P, et al. Visualization of immune cell infiltration in experimental viral myocarditis by (19)F MRI in vivo. MAGMA. 2014;27:101–6.

    Article  CAS  PubMed  Google Scholar 

  35. van Heeswijk RB, De Blois J, Kania G, et al. Selective in vivo visualization of immune-cell infiltration in a mouse model of autoimmune myocarditis by fluorine-19 cardiac magnetic resonance. Circ Cardiovasc Imaging. 2013;6:277–84.

    Article  PubMed  Google Scholar 

  36. Figueiredo S, Cutrin JC, Rizzitelli S, et al. MRI tracking of macrophages labeled with glucan particles entrapping a water insoluble paramagnetic Gd-based agent. Mol Imaging Biol. 2013;15:307–15.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Georgi Atanasov MD.

Additional information

G. Atanasov, C. Benzing, and M. Schmelzle have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Atanasov, G., Schierle, K., Hau, HM. et al. Prognostic Significance of Tumor Necrosis in Hilar Cholangiocarcinoma. Ann Surg Oncol 24, 518–525 (2017). https://doi.org/10.1245/s10434-016-5472-0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-016-5472-0

Keywords

Navigation